Corvese Brian — SEC insider filings

SEC reporting owner CIK 1393207. 30 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 30 filings on record, filed 2020-12-21 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
MiNK Therapeutics, Inc. (INKT)Director20——21
AGENUS INC (AGEN)Director9——11
Protagenic Therapeutics, Inc.\new (PTIX)Director1——1

Insider filings — Corvese Brian

FiledFormIssuerReported transactionsSource
2026-09-024MiNK Therapeutics, Inc. (INKT)Grant/award (A): 1,633 @ $10.95EDGAR
2026-08-114AGENUS INC (AGEN)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2026-06-024MiNK Therapeutics, Inc. (INKT)Grant/award (A): 1,640 @ $10.90 · Grant/award (A): 1,444 @ $12.38EDGAR
2026-04-284AGENUS INC (AGEN)Grant/award (A): 210,000 (derivative) @ $0EDGAR
2026-01-064MiNK Therapeutics, Inc. (INKT)Grant/award (A): 5,395 (derivative) @ $0EDGAR
2025-12-034MiNK Therapeutics, Inc. (INKT)Grant/award (A): 1,612 @ $11.09EDGAR
2025-09-114MiNK Therapeutics, Inc. (INKT)Grant/award (A): 3,225 (derivative) @ $0EDGAR
2025-09-034MiNK Therapeutics, Inc. (INKT)Grant/award (A): 1,290 @ $13.86EDGAR
2025-06-204AGENUS INC (AGEN)Grant/award (A): 750 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-044MiNK Therapeutics, Inc. (INKT)Grant/award (A): 2,494 @ $7.17EDGAR
2025-03-054MiNK Therapeutics, Inc. (INKT)Grant/award (A): 2,033 @ $8.79EDGAR
2024-12-034MiNK Therapeutics, Inc. (INKT)Grant/award (A): 24,400 @ $0.73EDGAR
2024-09-054MiNK Therapeutics, Inc. (INKT)Grant/award (A): 21,802 @ $0.82EDGAR
2024-06-184AGENUS INC (AGEN)Grant/award (A): 750 (derivative) @ $0EDGAR
2024-06-054MiNK Therapeutics, Inc. (INKT)Grant/award (A): 17,967 @ $0.99EDGAR
2024-04-224AGENUS INC (AGEN)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-03-294Protagenic Therapeutics, Inc.\new (PTIX)Grant/award (A): 43,750 (derivative) @ $1.74EDGAR
2024-03-054MiNK Therapeutics, Inc. (INKT)Grant/award (A): 18,816 @ $0.95EDGAR
2023-12-054MiNK Therapeutics, Inc. (INKT)Grant/award (A): 17,188 @ $1.04EDGAR
2023-09-064MiNK Therapeutics, Inc. (INKT)Grant/award (A): 12,244 @ $1.46EDGAR
2023-06-164MiNK Therapeutics, Inc. (INKT)Grant/award (A): 37,500 (derivative) @ $0EDGAR
2023-06-024MiNK Therapeutics, Inc. (INKT)Grant/award (A): 10,157 @ $1.76EDGAR
2023-03-034MiNK Therapeutics, Inc. (INKT)Grant/award (A): 8,553 @ $2.09EDGAR
2022-12-054MiNK Therapeutics, Inc. (INKT)Grant/award (A): 6,849 @ $2.61EDGAR
2022-09-194MiNK Therapeutics, Inc. (INKT)Grant/award (A): 13,646 @ $2.62EDGAR
2022-03-114MiNK Therapeutics, Inc. (INKT)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-02-084AGENUS INC (AGEN)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2021-07-024AGENUS INC (AGEN)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-06-214AGENUS INC (AGEN)Option exercise (M): 22,471 · Option exercise (M): 16,000 (derivative)EDGAR
2020-12-214AGENUS INC (AGEN)Grant/award (A): 100,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1393207 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs